skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Middle Aged remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The Interleukin-10 (-1082A/G) Polymorphism is Strongly Associated with Increased Risk for Oral Squamous Cell Carcinoma
The Interleukin-10 (-1082A/G) Polymorphism is Strongly Associated with Increased Risk for Oral Squamous Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Interleukin-10 (-1082A/G) Polymorphism is Strongly Associated with Increased Risk for Oral Squamous Cell Carcinoma

VAIRAKTARIS, Eleftherios ; YAPIJAKIS, Christos ; PATSOURIS, Efstratios ; SEREFOGLOU, Zoe ; DERKA, Spyridoula ; VASSILIOU, Stavros ; NKENKE, Emeka ; VYLLIOTIS, Antonis ; SPYRIDONIDOU, Sofia ; NEUKAM, Friedrich W ; SCHLEGEL, Karl A

Anticancer research, 2008-01, Vol.28 (1A), p.309-314 [Periódico revisado por pares]

Attiki: International Institute of Anticancer Research

Texto completo disponível

Citações Citado por
2
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Material Type:
Artigo 		Adicionar ao Meu Espaço

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Hehlmann, Rüdiger ; Voskanyan, Astghik ; Lauseker, Michael ; Pfirrmann, Markus ; Kalmanti, Lida ; Rinaldetti, Sebastien ; Kohlbrenner, Katharina ; Haferlach, Claudia ; Schlegelberger, Brigitte ; Fabarius, Alice ; Seifarth, Wolfgang ; Spieß, Birgit ; Wuchter, Patrick ; Krause, Stefan ; Kolb, Hans-Jochem ; Neubauer, Andreas ; Hossfeld, Dieter K ; Nerl, Christoph ; Gratwohl, Alois ; Baerlocher, Gabriela M ; Burchert, Andreas ; Brümmendorf, Tim H ; Hasford, Jörg ; Hochhaus, Andreas ; Saußele, Susanne ; Baccarani, Michele

Leukemia, 2020-08, Vol.34 (8), p.2074-2086 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial

Bennouna, Jaafar, MD ; Sastre, Javier, MD ; Arnold, Dirk, Prof ; Österlund, Pia, MD ; Greil, Richard, Prof ; Van Cutsem, Eric, Prof ; von Moos, Roger, MD ; Viéitez, Jose Maria, MD ; Bouché, Olivier, Prof ; Borg, Christophe, MD ; Steffens, Claus-Christoph, MD ; Alonso-Orduña, Vicente, MD ; Schlichting, Christoph, MD ; Reyes-Rivera, Irmarie, MD ; Bendahmane, Belguendouz, MD ; André, Thierry, Prof ; Kubicka, Stefan, Prof

The lancet oncology, 2013, Vol.14 (1), p.29-37 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)
Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

Schmitz, Norbert, Prof ; Nickelsen, Maike, MD ; Ziepert, Marita, PhD ; Haenel, Mathias, MD ; Borchmann, Peter, MD ; Schmidt, Christian, MD ; Viardot, Andreas, MD ; Bentz, Martin, MD ; Peter, Norma, MD ; Ehninger, Gerhard, Prof ; Doelken, Gottfried, Prof ; Ruebe, Christian, Prof ; Truemper, Lorenz, Prof ; Rosenwald, Andreas, Prof ; Pfreundschuh, Michael, Prof ; Loeffler, Markus, Prof ; Glass, Bertram, MD

The lancet oncology, 2012-12, Vol.13 (12), p.1250-1259 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings
Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Kubicka, S. ; André, T. ; von Moos, R. ; Österlund, P. ; Reyes-Rivera, I. ; Müller, T. ; Arnold, D. ; Balcke, P. ; Benedicic, B. ; Eisterer, W. ; Fridrik, M. ; Samonigg, H. ; Arts, J. ; De Man, M. ; Janssens, J. ; Benczikova, B. ; Prausova, J. ; Vitek, P. ; Jensen, B.B. ; Keldsen, N. ; Østerlind, K. ; Borg, C. ; Breysacher, G. ; Chone, L. ; Dourthe, L.-M. ; Faroux, R. ; Illory, J.F. ; Lecomte, T. ; Legoux, J.-L. ; Levache, B. ; Lotz, J.-P. ; Mabro, M. ; Manfredi, S. ; Matysiak Budnik, T. ; Miglianico, L. ; Pezet, D. ; Porneuf, M. ; Tournigand, C. ; Viret, F. ; Ychou, M. ; Bangerter, M. ; Bertram, M.E. ; Bohnsteen, B. ; Cordes, H.-J. ; Eggert, J. ; Engel, E. ; Florschütz, A. ; Freier, W. ; Freund, M. ; Göhler, T. ; Hagen, V. ; Hebart, H.F. ; Heike, M. ; Höffkes, H.-G. ; Kettner, E. ; Kneba, M. ; Kojouharoff, G. ; Kretzschmar, A. ; Kröning, H. ; Lammert, F. ; Papke, J. ; Rädle, J. ; Ridwelski, K. ; Rudi, J. ; Schmalenberger, A. ; Schwarzer, A. ; Schwerdtfeger, M. ; Selbach, J. ; Staib, P. ; Stauch, M. ; Steffens, C.-C. ; Stübs, P. ; Tischendorf, J. ; Tummes, D. ; Von Wichert, G.P.L. ; Zomorodbaksch, B. ; Bloemendal, H.J. ; Guren, T. ; Soerbye, H. ; Fragoso, R. ; Mellidez, J.C. ; Darwish, T. ; Aparicio, J. ; Aranda, E. ; Camara, J.C. ; Donnay, O. ; Escudero, P. ; Gallego Plazas, J. ; Gonzalez Flores, E. ; Gravalos, C. ; Guardeno, R. ; Juárez, A. ; Massuti Sureda, B. ; Tobena, M. ; Toral, J.C. ; Valenti, V. ; Berglund, A. ; Fernebro, E. ; Hess-Umbricht, V. ; Popescu, R.

Annals of oncology, 2013-09, Vol.24 (9), p.2342-2349 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG
Material Type:
Artigo 		Adicionar ao Meu Espaço

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

LENGFELDER, E ; HAFERLACH, C ; KERN, W ; REICHLE, A ; SERVE, H ; BERDEL, W. E ; BRAESS, J ; SPIEKERMANN, K ; WÖRMANN, B ; SAUERLAND, M.-C ; HEINECKE, A ; HIDDEMANN, W ; SAUSSELE, S ; HEHLMANN, R ; BÜCHNER, T ; HAFERLACH, T ; SCHULTHEIS, B ; SCHNITTGER, S ; LUDWIG, W.-D ; STAIB, P ; AUL, C ; GRÜNEISEN, A

Leukemia, 2009-12, Vol.23 (12), p.2248-2258 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients
Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Monoallelic CEBPA mutations in normal karyotype acute myeloid leukemia: independent favorable prognostic factor within NPM1 mutated patients

Dufour, Annika ; Schneider, Friederike ; Hoster, Eva ; Benthaus, Tobias ; Ksienzyk, Bianka ; Schneider, Stephanie ; Kakadia, Purvi M. ; Sauerland, Maria-Cristina ; Berdel, Wolfgang E. ; Büchner, Thomas ; Wörmann, Bernhard ; Braess, Jan ; Subklewe, Marion ; Hiddemann, Wolfgang ; Bohlander, Stefan K. ; Spiekermann, Karsten

Annals of hematology, 2012-07, Vol.91 (7), p.1051-1063 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
8
Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT
Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT
Material Type:
Artigo 		Adicionar ao Meu Espaço

Implementing a system of quality-of-life diagnosis and therapy for breast cancer patients: results of an exploratory trial as a prerequisite for a subsequent RCT

KLINKHAMMER-SCHALKE, M ; KOLLER, M ; EHRET, C ; STEINGER, B ; ERNST, B ; WYATT, J. C ; HOFSTÄDTER, F ; LORENZ, W

British journal of cancer, 2008-08, Vol.99 (3), p.415-422 [Periódico revisado por pares]

Basingstoke: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma
Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Modification and optimization of an established prognostic score after re-irradiation of recurrent glioma

Kessel, Kerstin A ; Hesse, Josefine ; Straube, Christoph ; Zimmer, Claus ; Schmidt-Graf, Friederike ; Schlegel, Jürgen ; Meyer, Bernhard ; Combs, Stephanie E Camphausen, Kevin

PloS one, 2017-07, Vol.12 (7), p.e0180457-e0180457 [Periódico revisado por pares]

United States: Public Library of Science

Texto completo disponível

Citações Citado por
10
High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients
High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients

Hönikl, Lisa Stefanie ; Lämmer, Friederike ; Gempt, Jens ; Meyer, Bernhard ; Schlegel, Jürgen ; Delbridge, Claire

Journal of neuro-oncology, 2020-05, Vol.147 (3), p.567-575 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (101)

Data de Publicação 

De até
Refinar
  1. Antes de1996  (6)
  2. 1996Até2002  (16)
  3. 2003Até2008  (17)
  4. 2009Até2015  (36)
  5. Após 2015  (30)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.